Lv13
88 积分 2023-03-16 加入
A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis
3小时前
已完结
A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis
1天前
求助中
A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis
2天前
已关闭
Dynamic Surveillance of the Cardiovascular Risk and Identification of Treatment Responders in Type 2 Diabetes Using A Machine Learning-Based Model
6天前
已完结
Real-world outcomes and tolerability of Janus kinase inhibitors in chronic spontaneous urticaria and chronic inducible urticaria: A single-center retrospective study
7天前
已完结
阿尔茨海默病高危因素管理专家共识（2026版）
8天前
已完结
The epidermal immune microenvironment plays a central role in the pathogenesis of psoriasis
14天前
已完结
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in moderate to severe chronic spontaneous urticaria patients with inadequate response to H1 antihistamines: a phase Ib, randomized, double-blind, placebo-controlled pilot study
1个月前
已完结
Higher body weight in Chinese patients is associated with treatment resistance to fixed-dose interleukin-17 inhibition with ixekizumab but not to weight-adjusted secukinumab therapy
1个月前
已完结
Targeted Synergy for Vitiligo in Refractory Areas: A Real-World Study of Ruxolitinib Cream Combined with 308-nm Excimer Lamp
1个月前
已关闭
皖公网安备34019202002308
